Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Uniphar PLC ( (GB:UPR) ) just unveiled an announcement.
Uniphar PLC has executed a share buyback transaction, purchasing 162,460 of its ordinary shares on Euronext Dublin, as part of its previously announced buyback program. The shares, bought at prices ranging from €2.6700 to €2.6950, will be cancelled, reducing the total number of shares in issue to 259,633,757. This move is part of Uniphar’s strategy to optimize its capital structure, potentially enhancing shareholder value and market confidence.
More about Uniphar PLC
Uniphar PLC operates in the healthcare sector, providing a range of services and products primarily focused on pharmaceutical distribution and supply chain solutions. The company is known for its market presence in Europe, particularly in Ireland and the UK, where it serves a diverse range of healthcare providers and stakeholders.
YTD Price Performance: 26.32%
Average Trading Volume: 33,352
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £576M
See more data about UPR stock on TipRanks’ Stock Analysis page.